Medtronic plc [NYSE: MDT] closed the trading session at $130.68 on 07/29/21. The day’s price range saw the stock hit a low of $129.50, while the highest price level was $131.24. The company report on July 29, 2021 that First Gynecological Procedures Performed with Medtronic Hugo™ Robotic-Assisted Surgery System.
The Six Gynecological Procedures Took Place Earlier This Month at Pacifica Salud Hospital in Panama City, Panama.
Medtronic plc (NYSE:MDT), the global leader in medical technology, announced the first gynecological (GYN) procedures with the Hugo™ robotic-assisted surgery (RAS) system. The six cases included hysterectomies and myomectomies performed by Salomón Zebede, M.D., and Juan Carlos López, M.D., last week at Pacifica Salud Hospital in Panama City, Panama.
The stocks have a year to date performance of 11.56 percent and weekly performance of 2.81 percent. The stock has been moved at 13.86 percent over the last six months. The stock has performed 4.93 percent around the most recent 30 days and changed -0.62 percent over the most recent 3-months.
If compared to the average trading volume of 4.30M shares, MDT reached to a volume of 3180413 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Medtronic plc [MDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $139.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Medtronic plc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 10, 2021. While these analysts kept the previous recommendation, Barclays raised their target price to Equal Weight. The new note on the price target was released on May 25, 2021, representing the official price target for Medtronic plc stock. Previously, the target price had yet another raise to $153, while Atlantic Equities analysts kept a Overweight rating on MDT stock.
The Average True Range (ATR) for Medtronic plc is set at 1.83, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 5.77. The Price to Book ratio for the last quarter was 3.42, with the Price to Cash per share for the same quarter was set at 8.14. Price to Free Cash Flow for MDT in the course of the last twelve months was 98.40 with Quick ratio for the last quarter at 2.10.
MDT stock trade performance evaluation
Medtronic plc [MDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.81. With this latest performance, MDT shares gained by 4.93% in over the last four-week period, additionally plugging by 13.86% over the last 6 months – not to mention a rise of 32.37% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 63.41, with the RSI for the last a single of trading hit 68.01, and the three-weeks RSI is set at 60.50 for Medtronic plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 125.97, while it was recorded at 129.61 for the last single week of trading, and 119.05 for the last 200 days.
Medtronic plc [MDT]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Medtronic plc [MDT] shares currently have an operating margin of +18.38 and a Gross Margin at +59.70. Medtronic plc’s Net Margin is presently recorded at +11.97.
Return on Total Capital for MDT is now 7.11, given the latest momentum, and Return on Invested Capital for the company is 4.74. Return on Equity for this stock inclined to 7.06, with Return on Assets sitting at 3.92. When it comes to the capital structure of this company, Medtronic plc [MDT] has a Total Debt to Total Equity ratio set at 53.29. Additionally, MDT Total Debt to Total Capital is recorded at 34.76, with Total Debt to Total Assets ending up at 29.44. Long-Term Debt to Equity for the company is recorded at 52.90, with the Long-Term Debt to Total Capital now at 34.51.
Reflecting on the efficiency of the workforce at the company, Medtronic plc [MDT] managed to generate an average of $40,067 per employee. Receivables Turnover for the company is 5.96 with a Total Asset Turnover recorded at a value of 0.33.Medtronic plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.60.
Earnings per share (EPS) analysis for Medtronic plc [MDT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic plc go to 10.94%.
Medtronic plc [MDT]: Insider Ownership positions
There are presently around $142,376 million, or 83.60% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 111,062,164, which is approximately -0.201% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 106,754,630 shares of the stock with an approximate value of $13.95 billion in MDT stocks shares; and STATE STREET CORP, currently with $7.15 billion in MDT stock with ownership of nearly -2.173% of the company’s market capitalization.
Positions in Medtronic plc stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 997 institutional holders increased their position in Medtronic plc [NYSE:MDT] by around 50,440,055 shares. Additionally, 800 investors decreased positions by around 39,193,481 shares, while 267 investors held positions by with 999,869,053 shares. The mentioned changes placed institutional holdings at 1,089,502,589 shares, according to the latest SEC report filing. MDT stock had 127 new institutional investments in for a total of 3,265,999 shares, while 80 institutional investors sold positions of 2,464,700 shares during the same period.